LaFond Elyse, Weidman Karissa, Lief Lindsay
Division of Pulmonary and Critical Care, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USA.
Curr Opin Pulm Med. 2021 May 1;27(3):199-204. doi: 10.1097/MCP.0000000000000767.
In under a year, coronavirus disease 2019 (COVID-19) has taken the lives of hundreds of thousands of Americans, leaving millions of survivors in its wake. The enormous number of people who survived acute illness but continue to have symptoms has highlighted the need for standardized evaluation of the post-COVID-19 patient. This review, based on the current literature and our experience, aims to guide the care of patients who have survived COVID-19.
The literature on this topic is rapidly expanding and covers both pulmonary and nonpulmonary complications of COVID-19. Pulmonary complications include dyspnea with normoxia, organizing pneumonia and pulmonary fibrosis. Nonpulmonary complications include neurologic, cardiac, and thromboembolic disease. Special consideration should be taken for COVID-19 survivors of intensive care.
The current review outlines the major clinical findings in post-COVID-19 patients and provides a guidelines to the evaluation and management of prolonged symptoms.
在不到一年的时间里，2019冠状病毒病（COVID-19）已夺走数十万美国人的生命，身后留下数百万幸存者。大量从急性疾病中幸存但仍有症状的人凸显了对COVID-19后患者进行标准化评估的必要性。本综述基于当前文献和我们的经验，旨在指导COVID-19幸存者的护理。
关于这一主题的文献正在迅速扩展，涵盖了COVID-19的肺部和非肺部并发症。肺部并发症包括氧分压正常情况下的呼吸困难、机化性肺炎和肺纤维化。非肺部并发症包括神经、心脏和血栓栓塞性疾病。对于入住重症监护病房的COVID-19幸存者应给予特别关注。
本综述概述了COVID-19后患者的主要临床发现，并为长期症状的评估和管理提供了指导。
